Apollo Management Holdings’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Hold	0	–	–	–	264
2022 Q1	–	Sell	-283,859	Closed	-$2.59M	–	340
2021 Q4	$2.59M	Buy	+283,859	New	+$2.59M	0.01%	134